First, we used a case–control gene expression dataset from GEO (GSE58294) to evaluate the potential differential mRNA expression of Annexin V in 69 cardioembolic stroke samples and 23 normal control samples. The gene discussed is ANXA5; the disease is cardioembolic stroke.